FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

14 results

apretude
(Cabotegravir)
ViiV Healthcare Company
Usage: APRETUDE is indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk of HIV-1. A negative HIV-1 test is required before starting treatment.
cabenuva
(cabotegravir and rilpivirine)
ViiV Healthcare Company
Usage: CABENUVA is indicated for the treatment of HIV-1 in adults and adolescents (12 years and older, 35 kg+) as a complete regimen to replace current antiretroviral therapy in those who are virologically suppressed, with no history of treatment failure or known resistance to its components.
combivir - lamivudine and zidovudine tablet, film coated
(Lamivudine And Zidovudine)
Viiv Healthcare Company
dovato
(dolutegravir sodium and lamivudine)
ViiV Healthcare Company
Usage: DOVATO is indicated for the treatment of HIV-1 infection in adults and adolescents (aged 12 and older, weighing at least 25 kg) either as a complete regimen for those with no prior treatment history or to replace the current regimen in virologically suppressed patients without resistance concerns.
epivir - lamivudine tablet, film coated
(Lamivudine)
Viiv Healthcare Company
epzicom - abacavir sulfate and lamivudine tablet, film coated
(Abacavir Sulfate And Lamivudine)
Viiv Healthcare Company
juluca
(dolutegravir sodium and rilpivirine hydrochloride)
ViiV Healthcare Company
Usage: JULUCA is indicated for treating HIV-1 infection in virologically suppressed adults, replacing their current antiretroviral regimen. Eligible patients must have maintained suppression for at least 6 months, have no treatment failures, and no known resistance to JULUCA's components.
retrovir - zidovudine capsule
(Zidovudine)
Viiv Healthcare Company
rukobia
(fostemsavir tromethamine)
ViiV Healthcare Company
Usage: RUKOBIA is indicated for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1, specifically for those failing their current antiretroviral regimen due to resistance, intolerance, or safety concerns, when used in combination with other antiretroviral medications.
selzentry - maraviroc tablet, film coated
(Maraviroc)
Viiv Healthcare Company

ViiV Healthcare Company drugs

apretude

cabenuva

combivir - lamivudine and zidovudine tablet, film coated

dovato

epivir - lamivudine tablet, film coated

epzicom - abacavir sulfate and lamivudine tablet, film coated

juluca

retrovir - zidovudine capsule

rukobia

selzentry - maraviroc tablet, film coated